Related Experiment Video

Updated: Jun 11, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against

Kimberly D Leuthner1, Celine Vidaillac, Chrissy M Cheung

  • 1Anti-Infective Research Laboratory, Department of Pharmacy Practice-4148, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI 48201, USA.

Antimicrobial Agents and Chemotherapy
|June 30, 2010
PubMed

Insights

TD-1792 shows potent in vitro activity against challenging Gram-positive pathogens, including vancomycin-resistant strains. This novel antibiotic demonstrates rapid bactericidal effects, offering a promising new option for treating multidrug-resistant Staphylococcus infections.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Gram-positive bacterial infections, particularly those caused by multidrug-resistant strains like methicillin-resistant Staphylococcus aureus (MRSA), pose a significant global health threat.
  • Existing antibiotics, including vancomycin, face challenges due to emerging resistance mechanisms such as vancomycin-intermediate Staphylococcus spp. (VISS), heteroresistant VISS (hVISS), and vancomycin-resistant S. aureus (VRSA).
  • Novel therapeutic agents with broad-spectrum activity and efficacy against resistant strains are urgently needed.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic.
  • To assess TD-1792's efficacy against clinical isolates of vancomycin-intermediate and vancomycin-resistant Staphylococcus species.
  • To compare TD-1792's activity with established antibiotics like vancomycin, daptomycin, linezolid, and quinupristin-dalfopristin.

Main Methods:

  • Determination of minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) for TD-1792 and comparator agents against VISS, hVISS, and VRSA isolates.
  • Conducting 24-hour time-kill experiments (TKs) with selected strains to assess bactericidal and bacteriostatic activity.
  • Evaluating the impact of 50% human serum on the activity of TD-1792 and daptomycin in vitro.

Main Results:

  • TD-1792 demonstrated the lowest MIC values (MIC(90) = 0.125 µg/mL) against VISS/hVISS isolates, indicating potent activity.
  • Both TD-1792 and daptomycin exhibited rapid bactericidal activity in time-kill experiments against all tested Staphylococcus isolates.
  • The presence of human serum had a minimal impact on TD-1792's activity in time-kill assays, unlike daptomycin.

Conclusions:

  • TD-1792 exhibits significant in vitro activity against multidrug-resistant Staphylococcus isolates, including strains with vancomycin resistance.
  • TD-1792 represents a promising candidate for treating infections caused by Gram-positive organisms, particularly those resistant to current therapies.
  • Its robust activity and minimal susceptibility to serum protein binding suggest potential for effective clinical application.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...